William Kammerer

451 total citations
14 papers, 336 citations indexed

About

William Kammerer is a scholar working on Oncology, Epidemiology and Pharmacology. According to data from OpenAlex, William Kammerer has authored 14 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in William Kammerer's work include Global Cancer Incidence and Screening (8 papers), Colorectal Cancer Screening and Detection (7 papers) and Cancer Risks and Factors (4 papers). William Kammerer is often cited by papers focused on Global Cancer Incidence and Screening (8 papers), Colorectal Cancer Screening and Detection (7 papers) and Cancer Risks and Factors (4 papers). William Kammerer collaborates with scholars based in United States and Germany. William Kammerer's co-authors include William Helsel, Lisa C. Richardson, Janet Royalty, Vicki B. Benard, Faye L. Wong, Krishna P. Sharma, Kristy Kenney, Amy DeGroff, Jacqueline W. Miller and Stephanie Melillo and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Public Health and Preventive Medicine.

In The Last Decade

William Kammerer

14 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Kammerer United States 8 271 89 71 41 20 14 336
Samuel Yaw Opoku Ghana 7 241 0.9× 128 1.4× 28 0.4× 34 0.8× 26 1.3× 22 371
Edmund Njeru Njagi United Kingdom 10 158 0.6× 56 0.6× 62 0.9× 28 0.7× 57 2.9× 24 370
Maja Nikšić United Kingdom 7 140 0.5× 38 0.4× 24 0.3× 55 1.3× 28 1.4× 12 221
John Harding Australia 7 244 0.9× 121 1.4× 26 0.4× 44 1.1× 46 2.3× 11 360
Oluwatosin Ayeni South Africa 11 197 0.7× 98 1.1× 38 0.5× 24 0.6× 60 3.0× 36 341
Sandra R. Distelhorst United States 8 226 0.8× 46 0.5× 46 0.6× 33 0.8× 90 4.5× 8 301
Jagdeep Singh India 11 88 0.3× 68 0.8× 37 0.5× 23 0.6× 13 0.7× 23 342
Melanie Powis Canada 10 214 0.8× 33 0.4× 59 0.8× 50 1.2× 70 3.5× 47 343
Krishna P. Sharma United States 9 215 0.8× 40 0.4× 55 0.8× 44 1.1× 23 1.1× 19 307
Hamideh Salimzadeh Iran 13 222 0.8× 55 0.6× 32 0.5× 74 1.8× 37 1.9× 28 362

Countries citing papers authored by William Kammerer

Since Specialization
Citations

This map shows the geographic impact of William Kammerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Kammerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Kammerer more than expected).

Fields of papers citing papers by William Kammerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Kammerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Kammerer. The network helps show where William Kammerer may publish in the future.

Co-authorship network of co-authors of William Kammerer

This figure shows the co-authorship network connecting the top 25 collaborators of William Kammerer. A scholar is included among the top collaborators of William Kammerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Kammerer. William Kammerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Scott, Lia C., Michele G. Beckman, Amy DeGroff, et al.. (2022). Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program. Preventing Chronic Disease. 19. E59–E59. 6 indexed citations
2.
DeGroff, Amy, Jacqueline W. Miller, Krishna P. Sharma, et al.. (2021). COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Preventive Medicine. 151. 106559–106559. 106 indexed citations
3.
Nadel, Marion R., Janet Royalty, Djenaba Joseph, et al.. (2019). Variations in Screening Quality in a Federal Colorectal Cancer Screening Program for the Uninsured. Preventing Chronic Disease. 16. E67–E67. 7 indexed citations
4.
DeGroff, Amy, Krishna P. Sharma, Kristy Kenney, et al.. (2018). Increasing Colorectal Cancer Screening in Health Care Systems Using Evidence-Based Interventions. Preventing Chronic Disease. 15. E100–E100. 49 indexed citations
5.
White, Arica, Jacqueline W. Miller, Janet Royalty, et al.. (2015). Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009–2012. Cancer Causes & Control. 26(5). 723–732. 8 indexed citations
6.
Pfister, Roman, et al.. (2013). Perioperatives Vorgehen bei Restless-legs-Syndrom. Der Anaesthesist. 62(12). 1023–1033. 1 indexed citations
7.
Kammerer, William. (2012). Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 107(2). 128–140. 5 indexed citations
8.
Benard, Vicki B., et al.. (2012). Timeliness of Cervical Cancer Diagnosis and Initiation of Treatment in the National Breast and Cervical Cancer Early Detection Program. Journal of Women s Health. 21(7). 776–782. 41 indexed citations
9.
Kammerer, William. (2011). Klinisch relevante pharmakokinetische Arzneimittelinteraktionen in der Intensivmedizin. Intensivmedizin und Notfallmedizin. 48(6). 480–492. 5 indexed citations
10.
Richardson, Lisa C., et al.. (2009). Timeliness of Breast Cancer Diagnosis and Initiation of Treatment in the National Breast and Cervical Cancer Early Detection Program, 1996–2005. American Journal of Public Health. 100(9). 1769–1776. 83 indexed citations
11.
Will, Julie C., et al.. (2007). A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women.. PubMed. 4(4). A89–A89. 8 indexed citations
12.
Richardson, Lisa C., et al.. (2007). Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Journal of Clinical Oncology. 25(18_suppl). 6571–6571. 2 indexed citations
13.
Kammerer, William. (2005). Arzneimittel in der Schwangerschaft. Der Gynäkologe. 38(9). 752–760. 1 indexed citations
14.
Jaffe, Julian J., et al.. (1973). ANTISCHISTOSOMAL ACTIVITY OF TUBERCIDIN IN MONKEYS. American Journal of Tropical Medicine and Hygiene. 22(1). 62–72. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026